These data demonstrate that hyperphosphatemia suppresses skeletal muscle cell differentiation through induction of oxidative stress, activation of the Nrf2/p62 signaling pathway, and disruption of mitochondrial function. This evidence concerns the gene NFE2L2 and hyperphosphatemia.